Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Print view.
German.
Contact.
Data entry.
Start.
Open Access.

Navigation/Search

Researchers.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Selected Publication:

Niedersuess-Beke, D; Pichler, R; Krauter, J; Luger, F; Vais, D; Taedcke, R; Aufderklamm, S; Stoiber, F; Shariat, SF; Schnabel, S; Gampenrieder, SP; Muehlmann, J; Spiegelberg, J; Bauernhofer, T; Banner, A; Weibrecht, S; Wiesinger, C; Miechowiecki, J; Heintel, D; Mayrhofer, K.
Treatment, tolerability and outcomes of enfortumab vedotin plus pembrolizumab in advanced urothelial carcinoma: An analysis of the Austrian enfortumab registry.
J CLIN ONCOL. 2025; 43(5_SUPPL): 736 Doi: 10.1200/JCO.2025.43.5_suppl.736
Web of Science FullText FullText_MUG

Authors Med Uni Graz:: Mayrhofer Katrin
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):